Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
Alejandro González Veliz, Interventional Cardiologist of Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“Getting a stent is often seen as the ‘solution.’
The artery is open.
Blood flow is restored.
The symptoms improve.
But here’s the problem:
Many patients think the disease is gone.
It’s not.
Coronary artery disease is a chronic, progressive condition.
A stent treats a specific blockage — but it does not cure the underlying process.
The biggest mistake after a stent?
Stopping treatment too soon or not taking it seriously enough.
Skipping medications like dual antiplatelet therapy or statins can have serious consequences, including stent thrombosis, recurrent heart attacks, or disease progression.
And it doesn’t stop with medication.
Long-term outcomes depend on what happens after the procedure:
- Controlling blood pressure
- Managing cholesterol
- Staying active
- Eating well
- Completely avoiding smoking
Because the procedure is only one moment in time.
The real treatment happens every day after.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils